539230 — Chemiesynth (Vapi) Income Statement
0.000.00%
- IN₹110.03m
- IN₹259.96m
- IN₹188.87m
- 19
- 55
- 66
- 44
Annual income statement for Chemiesynth (Vapi), fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | ARS | ARS | PRESS |
Standards: | IAS | IAS | — |
Status: | Final | Final | Final |
Revenue | |||
Total Revenue | 209 | 164 | 189 |
Cost of Revenue | |||
Gross Profit | 157 | 133 | 146 |
Selling / General / Administrative Expenses | |||
Depreciation and Amortization | |||
Other Operating Expenses | |||
Total Operating Expenses | 196 | 162 | 181 |
Operating Profit | 13.9 | 2.37 | 7.78 |
Gain / Loss on Sale of Assets | |||
Total Net Non Operating Interest Income / Expense | |||
Other Net Non Operating Costs | |||
Net Income Before Taxes | 8.14 | -4.51 | -0.082 |
Provision for Income Taxes | |||
Net Income After Taxes | 5.55 | -3.88 | -1.06 |
Net Income Before Extraordinary Items | |||
Net Income | 5.55 | -3.88 | -1.06 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||
Income Available to Common Shareholders Including Extraordinary Items | |||
Diluted Net Income | 5.55 | -3.88 | -1.06 |
Diluted Weighted Average Shares | |||
Basic EPS Including Extraordinary Items | |||
Diluted EPS Including Extraordinary Items | |||
Diluted EPS Excluding Extraordinary Items | |||
Normalised Income Before Taxes | |||
Normalised Income After Taxes | |||
Normalised Income Available to Common Shareholders | |||
Diluted Normalised EPS | 1.8 | -1.26 | -0.35 |